Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-8-28
pubmed:abstractText
All trans retinoic acid (atRA) has been shown to inhibit the growth of CAOV3 ovarian carcinoma cells and to elevate the level of p27 cyclin-dependent kinase inhibitor. We report here that phosphorylation at S10 residue is an important event in mediating p27 role in atRA induced growth arrest. atRA treatment of atRA sensitive CAOV3 cells increases the levels of S10 phospho-p27 in both nuclear and cytoplasmic cell compartments. This increase is accompanied by a decrease in the levels of skp2 protein. This effect was not observed in SKOV3 cells which are resistant to atRA growth inhibitory effect. An A10-p27 mutant that cannot be phosphorylated at S10 induces a dominant negative effect on the atRA effect on the levels and activity of endogenous p27. Overexpression of A10-p27 mutant renders CAOV3 cells more resistant to atRA treatment and reverses the effect that atRA has on p27 binding to CDKs, on CDK activity, and on the expression of S phase genes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10027389, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10086358, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10375532, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10385618, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10559916, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10559918, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10560516, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10662779, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10790373, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-10831586, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-11726503, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-11889117, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-12042314, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-12093740, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-12244301, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-12244302, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-12244303, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-12548010, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-15010468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-15040006, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-15057270, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-15528185, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-15579463, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-16391232, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-16618747, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-16780593, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-17627278, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-7624798, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-8494581, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-8596954, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-8754833, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-9054402, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-9168803, http://linkedlifedata.com/resource/pubmed/commentcorrection/18615582-9479824
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1097-4652
pubmed:author
pubmed:copyrightInfo
(c) 2008 Wiley-Liss, Inc
pubmed:issnType
Electronic
pubmed:volume
217
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
558-68
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18615582-Humans, pubmed-meshheading:18615582-Serine, pubmed-meshheading:18615582-Cytoplasm, pubmed-meshheading:18615582-Ovarian Neoplasms, pubmed-meshheading:18615582-Mutation, pubmed-meshheading:18615582-Phosphorylation, pubmed-meshheading:18615582-Female, pubmed-meshheading:18615582-Antineoplastic Agents, pubmed-meshheading:18615582-Cell Nucleus, pubmed-meshheading:18615582-Time Factors, pubmed-meshheading:18615582-Protein Binding, pubmed-meshheading:18615582-S Phase, pubmed-meshheading:18615582-Tretinoin, pubmed-meshheading:18615582-Cell Line, Tumor, pubmed-meshheading:18615582-Cell Proliferation, pubmed-meshheading:18615582-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18615582-Drug Resistance, Neoplasm, pubmed-meshheading:18615582-Transfection, pubmed-meshheading:18615582-Intracellular Signaling Peptides and Proteins
More...